arrow
C

Craig T. Jordan

university of colorado school of medicine
H指数:77
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD+ to eradicate KRAS-driven AML

同时靶向SLC25A51和琥珀酸脱氢酶选择性耗竭线粒体NAD+以根除KRAS驱动的AML

2026-08-050
PRE
A Phase 1/1b Study of the All-Oral Regimen CC-486 and Venetoclax in Acute Myeloid Leukemia

一项CC-486和Venetoclax口服方案在急性髓系白血病中的I/1b期研究

2026-07-280
OA
Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD+ to eradicate KRAS-driven AML

SLC25A51和琥珀酸脱氢酶的双重靶向选择性耗尽线粒体NAD以根除KRAS驱动的AML

2026-01-290
PRE
A generalized strategy to kill leukemic cells by targeting the regulatory systems governing mitochondrial membrane potential

一种通过靶向调控线粒体膜电位调控系统来杀灭白血病细胞的通用策略

2025-10-290
OAAI
Omacetaxine and azacitidine for untreated patients with myelodysplastic syndromes and excess blasts: a phase I/II clinical trial

奥马曲拉和氮杂胞苷用于初治的伴有过多 blasts 的骨髓增生异常综合征患者的 I/II 期临床试验

2025-10-100
OAAI
Taurine from tumour niche drives glycolysis to promote leukaemogenesis

肿瘤微环境中的牛磺酸驱动糖酵解以促进白血病发生

NATURE
IF48.5
2025-05-140
OA
Omacetaxine and Azacitidine for Newly Diagnosed Patients with Myelodysplastic Syndromes and Excess Blasts

奥马扎克汀和阿扎胞苷用于新诊断的伴有过多原始细胞的骨髓增生异常综合征患者

BLOOD
IF23.1
2024-11-050
PRE
Multiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemia

多组学分析确定非裔美国急性髓系白血病患者的生存预测因子

2024-10-041
OAAI
Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium
2024-05-231
OA
An immunophenotype-coupled transcriptomic atlas of human hematopoietic progenitors
2024-03-216
OAAI
Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine

通过数字聚合酶链反应评估的多基因可测量的残留疾病在接受维奈托克/阿扎胞苷的急性髓性白血病患者中具有临床和生物学效用

2023-12-143
OAAI
A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy
2023-06-2631
OA